1. A blinded randomized study comparing intubating conditions after either rocuronium 0.6 mg·kg
- Author
-
Matias, Vested, Anne Marie, Sørensen, Cecilie, Bjerring, Rasmus E, Christensen, Felicia, Dinesen, Malene, Vang, Alexander, Gilvanoff, Thea Ellehammer, Hansen, Tatiana, Nielsen, and Lars S, Rasmussen
- Subjects
Remifentanil ,Double-Blind Method ,Piperidines ,Intubation, Intratracheal ,Humans ,Androstanols ,Rocuronium ,Propofol ,Anesthetics, Intravenous ,Aged ,Neuromuscular Nondepolarizing Agents - Abstract
To facilitate tracheal intubation, either a neuromuscular blocking agent or a bolus dose of remifentanil can be administered. We hypothesized that rocuronium 0.6 mg·kgA total of 78 patients were randomized to either rocuronium 0.6 mg·kgNo difference in the occurrence of excellent intubating conditions was found comparing the rocuronium group with the remifentanil group; 10 (28%) versus 15 (39%) (p = .29), respectively, relative risk = 0.72. Interventions against hypotension were used in 24 (67%) versus 28 (74%) (p = .51), respectively. Hoarseness and sore throat 24 h postoperatively were found in 37% versus 35% p = .86, and 14% versus 5% p = .20, respectively. The IDS score was 2 versus 2 p = .48.No difference in intubating conditions was found 2 min after the administration of either rocuronium 0.6 mg·kgNCT04287426.
- Published
- 2021